References
A. H. Anis, P. X. Tugwell, G. A. Wells and D. G. Stewart. 1996. A Cost Effectiveness Analysis of Cyclosporine in Rheumatoid Arthritis Journal of Rheumatology 23: 4 609 - 16 (PubMed)
K. Armstrong, T.-M. Chen, D. Albert, T. C. Randall and J. S. Schwartz. 2001. Cost-Effectiveness of Raloxifene and Hormone Replacement Therapy in Postmenopausal Women: Impact of Breast Cancer Risk Obstetrics and Gynaecology 98: 6 996 - 1003
S.-C. Bae, M. Corzillius, K. M. Kuntz and M. H. Liang. 2003. Cost-Effectiveness of Low Dose Corticosteroids versus Non-steroidal Anti-inflammatory Drugs and COX-2 Specific Inhibitors in the Long-Term Treatment of Rheumatoid Arthritis Rheumatology 42: 1 46 - 53 (PubMed)
W. Bolten, A. Kempel-Waibel and W. Pforringer. 1998. Analysis of the Cost of Illness in Backache Medizinische Klinik 93: 6 388 - 93 (PubMed)
R. W. Chang, J. M. Pellissier and G. B. Hazen. 1996. A Cost-Effectiveness Analysis of Total Hip Arthroplasty for Osteoarthritis of the Hip Journal of the American Medical Association 275: 11 858 - 65 (PubMed)
D. Coyle, A. Cranney, K. M. Lee, V. Welch and P. Tugwell. 2001. Cost Effectiveness of Nasal Calcitonin in Postmenopausal Women: Use of Cochrane Collaboration Methods for Meta-Analysis within Economic Evaluation Pharmacoeconomics 19: 5, part 2 565 - 75 (PubMed)
J. Darmawan, H. A. Valkenburg, K. D. Muirden and R. D. Wigley. 1995. The Prevalence of Soft Tissue Rheumatism in Indonesia: A WHO-ILAR COPCORD Study Rheumatology International 15: 3 121 - 24 (PubMed)
R. Fleurence, D. J. Torgerson and D. M. Reid. 2002. Cost-Effectiveness of Hormone Replacement Therapy for Fracture Prevention in Young Postmenopausal Women: An Economic Analysis Based on a Prospective Cohort Study Osteoporosis International 13: 8 637 - 43 (PubMed)
A. D. Furlan, L. Brosseau, M. Imamura and E. Irvan. 2002. Massage for Low-Back Pain: A Systematic Review within the Framework of the Cochrane Collaboration Back Review Group Spine 27: 17 1896 - 910 (PubMed)
S. E. Gabriel, M. E. Campion and W. M. O'Fallon. 1994. A Cost-Utility Analysis of Misoprostol Prophylaxis for Rheumatoid Arthritis Patients Receiving Nonsteroidal Antiinflammatory Drugs Arthritis and Rheumatology 37: 3 333 - 41
S. E. Gabriel, D. Coyle and L. W. Moreland. 2001. A Clinical and Economic Review of Disease-Modifying Antirheumatic Drugs Pharmacoeconomics 19: 7 715 - 28 (PubMed)
S. E. Gabriel, P. Tugwell and M. Drummond. 2002. Progress towards an OMERACT-ILAR Guideline for Economic Evaluations in Rheumatology Annals of the Rheumatic Diseases 61: 4 370 - 73 (PubMed)
R. J. Gatchel, P. B. Polatin, C. Noe, M. Gardea, C. Pulliam and J. Thompson. 2003. Treatment- and Cost-Effectiveness of Early Intervention for Acute Low-Back Pain Patients: A One-Year Prospective Study Journal of Occupational Rehabilitation 13: 1 1 - 9 (PubMed)
E. Geelhoed, A. Harris and R. Prince. 1994. Cost-Effectiveness Analysis of Hormone Replacement Therapy and Lifestyle Intervention for Hip Fracture Australian Journal of Public Health 18: 2 153 - 60 (PubMed)
M. Hazes and A. D. Woolf. 2000. The Bone and Joint Decade 2000-2010 Journal of Rheumatology 27: 1 - 3 (PubMed)
R. A. Hughes, M. E. Carr, A. Huggett and C. E. Thwaites. 2002. Review of the Function of a Telephone Helpline in the Treatment of Outpatients with Rheumatoid Arthritis Annals of the Rheumatic Diseases 61: 4 341 - 45 (PubMed)
S. Jitapunkul, C. Kunanusont, W. Phoolcharoen, P. Suriyawongpaisal and S. Ebrahim. 2003. Determining Public Health Priorities for an Ageing Population: The Value of a Disability Survey Southeast Asian Journal of Tropical Medicine and Public Health 34: 4 929 - 36 (PubMed)
B. Jonsson, J. Kanis, A. Dawson, A. Oden and O. Johnell. 1999. Effect and Offset of Effect of Treatments for Hip Fracture on Health Outcomes Osteoporosis International 10: 3 193 - 99 (PubMed)
J. A. Kanis, J. E. Brazier, M. Stevenson, N. W. Calvert and M. Jones. 2002. Treatment of Established Osteoporosis: A Systematic Review and Cost-Utility Analysis Health Technology Assessment 6: 29 1 - 146
P. T. Katzmarzyk, N. Gledhill and R. J. Shephard. 2000. The Economic Burden of Physical Inactivity in Canada Canadian Medical Association Journal 163: 11 1435 - 40 (PubMed)
J. Lord, C. Victor, P. Littlejohns, F. M. Ross and J. S. Axford. 1999. Economic Evaluation of a Primary Care-Based Education Programme for Patients with Osteoarthritis of the Knee Health Technology Assessment 3: 23 1 - 55
A. Maetzel, V. Strand, P. Tugwell, G. Wells and C. Bombardier. 2002. Cost-Effectiveness of Adding Leflunomide to a Five-Year Strategy of Conventional Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis Arthritis and Rheumatism 47: 6 655 - 61 (PubMed)
C. J. McCabe, R. L. Akehurst, J. Kirsch, M. Whitfield, M. Backhouse, A. D. Woolf , et al. , et al.. 1998. Choice of NSAID and Management Strategy in Rheumatoid Arthritis and Osteoarthritis: The Impact on Costs and Outcomes in the U.K Pharmacoeconomics 14: 2 191 - 99 (PubMed)
P. E. McGill and G. O. Oyoo. 2002. Rheumatic Disorders in Sub-Saharan Africa East African Medical Journal 79: 4 214 - 16 (PubMed)
D. C. E. Nordstrom, Y. T. Kontinnen, S. Solovieva, C. Friman and S. Santavirta. 1996. In- and Out-Patient Rehabilitation in Rheumatoid Arthritis Scandinavian Journal of Rheumatology 25: 4 200 - 6 (PubMed)
A. Norlund. 1996. Prevention of Osteoporosis: A Cost-Effectiveness Analysis Regarding Fractures Scandinavian Journal of Rheumatology 25: Suppl. 103 42 - 45 (PubMed)
D. L. Patrick, S. D. Ramsey, A. C. Spencer, S. Kinne, B. Belza and T. D. Topolski. 2001. Economic Evaluation of Aquatic Exercise for Persons with Osteoarthritis Medical Care 39: 5 413 - 24 (PubMed)
L. Segal, S. E. Day, A. B. Chapman and R. H. Osborne. 2004. Can We Reduce Disease Burden from Osteoarthritis Medical Journal of Australia 180: Suppl. 5 S11 - 17 (PubMed)
Symmons D., C. Mathers, and B. Pfleger. 2004a. Global Burden of Osteoarthritis in the Year 2000. Geneva: World Health Organization.
———. 2004b. The Global Burden of Rheumatoid Arthritis in the Year 2000. Geneva: World Health Organization.
M. S. Thompson, J. L. Read, H. C. Hutchings, M. Paterson and E. D. J. Harris. 1988. The Cost Effectiveness of Auranofin: Results of a Randomized Clinical Trial Journal of Rheumatology 15: 1 35 - 42 (PubMed)
G. W. Torrance, J. P. Raynauld, V. Walker, C. H. Goldsmith, N. Bellamy, P. A. Band , et al. , et al.. 2002. A Prospective, Randomized, Pragmatic, Health Outcomes Trial Evaluating the Incorporation of Hylan G-F 20 into the Treatment Paradigm for Patients with Knee Osteoarthritis (Part 2 of 2): Economic Results Osteoarthritis and Cartilage 10: 7 518 - 27 (PubMed)
H. E. M. van Dieten, I. B. C. Korthals-De Bros, M. W. van Tulder, W. F. Lems, B. A. C. Dijkmans and M. Boers. 2000. Systematic Review of the Cost Effectiveness of Prophylactic Treatments in the Prevention of Gastropathy in Patients with Rheumatoid Arthritis or Osteoarthritis Taking Non-steroidal Anti-inflammatory Drugs Annals of the Rheumatic Diseases 59: 10 753 - 59 (PubMed)
A. van Tubergen, A. Boonen, R. Landewe, M. Molken, D. van der Heijde, A. Hidding and S. van der Linden. 2002. Cost Effectiveness of Combined Spa-Exercise Therapy in Ankylosing Spondylitis: A Randomized Controlled Trial Arthritis and Rheumatism 47: 5 459 - 67 (PubMed)
van Tulder, M. W., R. Esmail, C. Bombardier, and B. W. Koes. 2003. "Back Schools for Non-specific Low Back Pain." Cochrane Library (2), Update Software, Oxford, U.K.
A. C. Verhoeven, J. C. Bibo, M. Boers, G. L. Engel and S. van der Linden. 1998. Cost-Effectiveness and Cost-Utility of Combination Therapy in Early Rheumatoid Arthritis: Randomized Comparison of Combined Step-Down Prednisolone, Methotrexate, and Sulphasalazine with Sulphasalazine Alone British Journal of Rheumatology 37: 10 1102 - 9 (PubMed)
WHO (World Health Organization). 2000. "Global Burden of Disease." Global Programme on Evidence for Health Policy Discussion Paper 50, WHO, Geneva.
———. 2003. "The Burden of Musculoskeletal Conditions at the Start of the New Millennium." WHO Technical Report Series 919, WHO, Geneva.
———. 2004. Annex 3: Burden of Disease in Disability-Adjusted Life-Years (DALYs), by Cause, Sex, and Mortality Stratum, in WHO Regions, Estimates for 2001. Geneva: WHO. http://www.who.int/whr/2002/annex/en/print.html.
M. S. Willis. 2002. The Health Economics of Calcium and Vitamin D3 for the Prevention of Osteoporotic Hip Fractures in Sweden International Journal of Technology Assessment in Health Care 18: 4 791 - 807 (PubMed)
